ADMA - ADMA Biologics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.00
DETAILS
HIGH:
$24.00
LOW:
$18.00
MEDIAN:
$21.00
CONSENSUS:
$21.00
UPSIDE:
154.85%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue | 510.2 | 426.5 | 258.2 | 154.1 | 80.9 | 42.2 | 29.3 | 17.0 | 22.8 | 10.7 | 7.2 | 5.9 | 3.1 | 1.1 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 217.4 | 206.9 | 169.3 | 118.8 | 79.8 | 61.3 | 39.5 | 42.2 | 29.2 | 6.4 | 4.3 | 3.7 | 2.0 | 0.7 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 292.8 | 219.6 | 88.9 | 35.3 | 1.2 | (19.1) | (10.2) | (25.2) | (6.4) | 4.3 | 2.9 | 2.2 | 1.0 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||||||||||||||||
| R&D Expenses | 4.8 | 1.8 | 3.3 | 3.6 | 3.6 | 5.9 | 2.3 | 3.9 | 6.2 | 7.7 | 7.0 | 9.5 | 9.3 | 3.5 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 91.6 | 74.1 | 59.0 | 52.5 | 42.9 | 35.1 | 25.9 | 22.5 | 18.1 | 8.5 | 6.7 | 4.8 | 4.4 | 3.1 | 0.0 | 0.0 | 0 | 0 | 0.0 |
| Other Expenses | 5.0 | 4.6 | 5.0 | 18.6 | 13.0 | 4.9 | 3.0 | (0.1) | (0.0) | 0.0 | 4.6 | (0.1) | 0.1 | 1.7 | 0 | 0 | (20.0) | 24.9 | 29.7 |
| Operating Expenses | 101.3 | 80.6 | 67.3 | 74.6 | 59.5 | 45.8 | 31.3 | 35.1 | 32.1 | 21.6 | 18.4 | 18.2 | 16.1 | 8.4 | 0.0 | 0.0 | (20.0) | 24.9 | 29.7 |
| Operating Income | |||||||||||||||||||
| Operating Income | 191.4 | 139.0 | 21.6 | (39.4) | (58.4) | (64.9) | (41.4) | (60.3) | (39.3) | (17.3) | (15.5) | (16.0) | (15.0) | (7.9) | (0.0) | (0.0) | (20.0) | (24.9) | (29.7) |
| Interest Expense | 7.1 | 13.9 | 25.0 | 19.3 | 13.1 | 12.0 | 9.0 | 5.5 | 3.3 | 2.2 | 1.8 | 1.3 | 0.6 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 1.9 | 2.1 | 1.6 | 0.0 | 0.0 | 0.3 | 0.8 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0.0 |
| Profitability | |||||||||||||||||||
| EBITDA | 197.9 | 147.7 | 5.1 | (39.5) | (53.1) | (59.8) | (36.0) | (56.8) | (39.3) | (16.8) | (15.7) | (15.8) | (14.7) | (7.7) | (4.4) | (5.0) | (20.0) | (24.9) | (29.7) |
| EBIT | 189.8 | 139.6 | (3.2) | (46.6) | (58.6) | (63.8) | (39.3) | (60.2) | (40.5) | (17.3) | (16.1) | (16.1) | (14.9) | (7.9) | (4.6) | (5.2) | 0 | 0 | 0 |
| Income Before Tax | 182.7 | 125.7 | (28.2) | (65.9) | (71.6) | (75.7) | (48.3) | (65.7) | (43.8) | (19.5) | (18.0) | (17.4) | (15.5) | (7.9) | (0.0) | (0.0) | (20.0) | (24.9) | (29.7) |
| Income Tax Expense | 35.7 | (72.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.6) | 0 | (0.6) | (0.0) | (0.0) | 0 | 0 | 0 |
| Net Income | 146.9 | 197.7 | (28.2) | (65.9) | (71.6) | (75.7) | (48.3) | (65.7) | (43.8) | (19.5) | (18.0) | (16.8) | (15.5) | (7.3) | (0.0) | (0.0) | (20.0) | (24.9) | (29.7) |
| Per Share Data | |||||||||||||||||||
| EPS (Basic) | 0.62 | 0.85 | -0.13 | -0.43 | -0.61 | -1.02 | -1.05 | -1.45 | -1.91 | -1.61 | -1.73 | -1.81 | -2.38 | -1.39 | -0.01 | -0.01 | -8.00 | -9956.40 | -11.87 |
| EPS (Diluted) | 0.60 | 0.81 | -0.13 | -0.43 | -0.61 | -1.02 | -1.05 | -1.45 | -1.91 | -1.61 | -1.73 | -1.81 | -2.38 | -1.39 | -0.00 | -0.00 | -0.02 | -0.02 | -0.01 |
| Shares Outstanding | 238.3 | 233.1 | 224.0 | 197.9 | 139.6 | 86.1 | 54.3 | 45.2 | 22.9 | 12.2 | 10.4 | 9.3 | 6.5 | 5.3 | 2.5 | 2.5 | 2.5 | 0.0 | 2.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||
| Cash & Cash Equivalents | 87.6 | 103.1 | 51.4 | 86.5 | 51.1 | 55.9 | 26.8 | 22.8 | 43.1 | 9.9 | 8.7 | 2.6 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.4 | 0 | 0 |
| Net Receivables | 158.4 | 50.0 | 27.4 | 15.5 | 28.6 | 13.2 | 3.5 | 1.4 | 3.9 | 1.0 | 0 | 0 |
| Inventory | 206.5 | 170.2 | 172.9 | 163.3 | 124.7 | 81.5 | 53.1 | 18.6 | 12.6 | 5.0 | 0 | 0 |
| Other Current Assets | 14.0 | 8.0 | 5.3 | 5.1 | 0 | 0 | 0 | 1.8 | 2.1 | 0 | 0 | 0 |
| Total Current Assets | 466.5 | 331.4 | 257.0 | 270.4 | 208.7 | 153.7 | 85.8 | 44.5 | 63.2 | 21.7 | 8.7 | 2.6 |
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment | 71.7 | 63.3 | 63.5 | 68.7 | 58.2 | 45.9 | 33.0 | 30.1 | 30.5 | 2.0 | 0 | 0 |
| Goodwill | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 0 | 0 | 0 |
| Intangible Assets | 0.6 | 0.5 | 0.5 | 1.0 | 1.7 | 2.4 | 3.2 | 4.0 | 4.8 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 8.6 | 5.7 | 4.7 | 4.8 | 4.1 | 2.1 | 1.6 | 6.7 | 6.0 | 0.0 | 0 | 0 |
| Total Non-Current Assets | 157.7 | 157.3 | 72.2 | 78.1 | 67.5 | 53.9 | 41.3 | 44.3 | 44.9 | 2.0 | 0 | 0 |
| Total Assets | 624.2 | 488.7 | 329.2 | 348.5 | 276.3 | 207.7 | 127.1 | 88.9 | 108.0 | 23.7 | 8.7 | 2.6 |
| Current Liabilities | ||||||||||||
| Account Payables | 22.5 | 20.2 | 15.7 | 13.2 | 12.4 | 11.1 | 9.2 | 5.9 | 5.9 | 2.6 | 0 | 0 |
| Short-Term Debt | 3.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 6.1 | 0 | 0 |
| Deferred Revenue | 1.4 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0 |
| Other Current Liabilities | 41.7 | 1.9 | 2.4 | 1.8 | 16.0 | 0.2 | 0 | (0.1) | 0 | 0 | 0 | 16.0 |
| Total Current Liabilities | 69.5 | 55.5 | 49.8 | 39.3 | 30.4 | 19.9 | 14.0 | 9.6 | 9.4 | 11.2 | 11.5 | 16.0 |
| Non-Current Liabilities | ||||||||||||
| Long-Term Debt | 76.0 | 72.3 | 130.6 | 142.8 | 94.9 | 93.0 | 83.2 | 44.1 | 43.0 | 14.1 | 0 | 16.0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (40.5) | 0 | (8.0) | 0 | 0 |
| Other Non-Current Liabilities | 1.4 | 1.7 | 2.1 | 1.9 | 0.4 | 0.1 | 0.1 | 12.9 | 12.7 | 0.1 | 0 | 0 |
| Total Non-Current Liabilities | 77.4 | 84.1 | 144.2 | 157.2 | 104.7 | 99.5 | 86.9 | 59.5 | 58.2 | 16.9 | 11.5 | 16.0 |
| Total Liabilities | 146.9 | 139.7 | 194.0 | 196.5 | 135.1 | 119.4 | 100.9 | 69.1 | 67.7 | 28.1 | 8.7 | 2.6 |
| Stockholders' Equity | ||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 |
| Retained Earnings | (161.7) | (308.6) | (506.3) | (478.0) | (412.1) | (340.5) | (264.7) | (216.4) | (150.7) | (106.9) | 0 | 0 |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (3.4) | (1.3) | (2.2) | 0 | 0 |
| Total Stockholders' Equity | 477.3 | 349.0 | 135.2 | 152.0 | 141.2 | 88.2 | 26.2 | 19.8 | 40.3 | (4.5) | (2.8) | (13.3) |
| Total Liabilities & Equity | 624.2 | 488.7 | 329.2 | 348.5 | 276.3 | 207.7 | 127.1 | 88.9 | 108.0 | 23.7 | 8.7 | 2.6 |
| Debt Metrics | ||||||||||||
| Total Debt | 79.9 | 82.1 | 141.4 | 154.4 | 102.9 | 97.7 | 84.7 | 44.2 | 43.0 | 20.3 | 11.5 | 16.0 |
| Net Debt | (7.7) | (21.0) | 90.1 | 67.9 | 51.8 | 41.7 | 58.0 | 21.5 | (0.1) | 10.3 | 2.8 | 13.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 146.9 | 197.7 | (28.2) | (65.9) | (71.6) | (75.7) | (48.3) | (65.7) | (43.8) | (19.5) |
| Depreciation & Amortization | 8.1 | 8.0 | 8.3 | 7.1 | 5.5 | 3.9 | 3.3 | 3.4 | 2.7 | 0.5 |
| Stock-Based Compensation | 20.0 | 13.6 | 6.2 | 5.2 | 3.5 | 2.9 | 2.7 | 0 | 1.6 | 1.3 |
| Change in Working Capital | (139.6) | (18.5) | (10.1) | (18.3) | (51.7) | (33.8) | (33.5) | (3.7) | (0.3) | (1.0) |
| Other Non-Cash Items | 3.9 | 2.2 | 32.6 | 12.4 | 1.8 | 1.6 | (0.3) | 1.0 | 0.6 | 0.5 |
| Operating Cash Flow | 50.4 | 118.7 | 8.8 | (59.5) | (112.4) | (102.0) | (76.2) | (62.7) | (37.3) | (18.3) |
| Investing Activities | ||||||||||
| Capital Expenditure | (22.6) | (8.6) | (5.0) | (13.9) | (13.5) | (12.7) | (3.8) | (2.1) | (2.7) | (0.1) |
| Acquisitions | 1 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 12.5 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (12.5) | (15.7) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.4 | 16.7 |
| Other Investing Activities | (0.3) | (0.3) | (0.2) | 0 | 0 | 0.0 | 0 | 0 | 12.5 | 0 |
| Investing Cash Flow | (21.9) | (8.6) | (5.0) | (13.9) | (13.5) | (12.7) | (3.8) | (2.1) | 15.2 | 0.9 |
| Financing Activities | ||||||||||
| Net Debt Issuance | (3.2) | (60) | (23.6) | 51.7 | (0.0) | 13.5 | 42.5 | (0.0) | 25.0 | 4.0 |
| Stock Repurchased | (31.9) | 0 | (1.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (11.9) | (5.8) | (14.0) | (7.5) | (0.1) | (0.8) | (10.9) | 0.0 | (3.4) | (0.0) |
| Financing Cash Flow | (44.0) | (58.3) | (39.0) | 108.9 | 121.0 | 143.9 | 80.0 | 42.9 | 60.8 | 16.8 |
| Cash Position | ||||||||||
| Net Change in Cash | (15.5) | 51.8 | (35.2) | 35.4 | (4.8) | 29.2 | (0.0) | (21.9) | 38.7 | (0.5) |
| Cash at Beginning | 103.1 | 51.4 | 86.5 | 51.1 | 55.9 | 26.8 | 26.8 | 48.6 | 9.9 | 10.4 |
| Cash at End | 87.6 | 103.1 | 51.4 | 86.5 | 51.1 | 55.9 | 26.8 | 26.8 | 48.6 | 9.9 |
| Free Cash Flow | 27.8 | 110.1 | 3.8 | (73.4) | (125.9) | (114.7) | (80.0) | (64.8) | (39.9) | (18.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | 510.2 | 426.5 | 258.2 | 154.1 | 80.9 | 42.2 | 29.3 | 17.0 | 22.8 | 10.7 | 7.2 | 5.9 | 3.1 | 1.1 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 292.8 | 219.6 | 88.9 | 35.3 | 1.2 | (19.1) | (10.2) | (25.2) | (6.4) | 4.3 | 2.9 | 2.2 | 1.0 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 191.4 | 139.0 | 21.6 | (39.4) | (58.4) | (64.9) | (41.4) | (60.3) | (39.3) | (17.3) | (15.5) | (16.0) | (15.0) | (7.9) | (0.0) | (0.0) | (20.0) | (24.9) | (29.7) |
| Net Income | 146.9 | 197.7 | (28.2) | (65.9) | (71.6) | (75.7) | (48.3) | (65.7) | (43.8) | (19.5) | (18.0) | (16.8) | (15.5) | (7.3) | (0.0) | (0.0) | (20.0) | (24.9) | (29.7) |
| EPS (Diluted) | 0.60 | 0.81 | -0.13 | -0.43 | -0.61 | -1.02 | -1.05 | -1.45 | -1.91 | -1.61 | -1.73 | -1.81 | -2.38 | -1.39 | -0.00 | -0.00 | -0.02 | -0.02 | -0.01 |
| Balance Sheet | |||||||||||||||||||
| Cash & Equivalents | 87.6 | 103.1 | 51.4 | 86.5 | 51.1 | 55.9 | 26.8 | 22.8 | 43.1 | 9.9 | 8.7 | 2.6 | |||||||
| Total Assets | 624.2 | 488.7 | 329.2 | 348.5 | 276.3 | 207.7 | 127.1 | 88.9 | 108.0 | 23.7 | 8.7 | 2.6 | |||||||
| Total Debt | 79.9 | 82.1 | 141.4 | 154.4 | 102.9 | 97.7 | 84.7 | 44.2 | 43.0 | 20.3 | 11.5 | 16.0 | |||||||
| Stockholders' Equity | 477.3 | 349.0 | 135.2 | 152.0 | 141.2 | 88.2 | 26.2 | 19.8 | 40.3 | (4.5) | (2.8) | (13.3) | |||||||
| Cash Flow | |||||||||||||||||||
| Operating Cash Flow | 50.4 | 118.7 | 8.8 | (59.5) | (112.4) | (102.0) | (76.2) | (62.7) | (37.3) | (18.3) | |||||||||
| Capital Expenditure | (22.6) | (8.6) | (5.0) | (13.9) | (13.5) | (12.7) | (3.8) | (2.1) | (2.7) | (0.1) | |||||||||
| Free Cash Flow | 27.8 | 110.1 | 3.8 | (73.4) | (125.9) | (114.7) | (80.0) | (64.8) | (39.9) | (18.3) | |||||||||